Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GSK

GSK Plc ADR

Sep 20 • 04:00PM ET

40.80

Dollar change -0.82
Percentage change -1.97	%

Healthcare • Drug Manufacturers - General • United Kingdom • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: FVD PPH GCOW AVDE RODM FENI PLDR APIE JHMD AVIV

Scroll to Statements

Index	-	P/E	16.48	EPS (ttm)	2.48	Insider Own	0.01%	Shs Outstand	2.04B	Perf Week	-5.14%
Market Cap	83.21B	Forward P/E	8.93	EPS next Y	4.57	Insider Trans	0.00%	Shs Float	2.04B	Perf Month	-2.51%
Income	5.09B	PEG	3.43	EPS next Q	1.23	Inst Own	15.33%	Short Float	0.53%	Perf Quarter	0.79%
Sales	39.58B	P/S	2.10	EPS this Y	4.17%	Inst Trans	0.60%	Short Ratio	3.04	Perf Half Y	-3.71%
Book/sh	8.91	P/B	4.58	EPS next Y	11.07%	ROA	6.84%	Short Interest	10.91M	Perf Year	7.17%
Cash/sh	1.85	P/C	22.07	EPS next 5Y	4.80%	ROE	29.70%	52W Range	33.67 - 45.92	Perf YTD	10.09%
Dividend Est.	1.56 (3.83%)	P/FCF	11.83	EPS past 5Y	4.23%	ROI	14.42%	52W High	-11.16%	Beta	0.66
Dividend TTM	1.53 (3.75%)	Quick Ratio	0.54	Sales past 5Y	-1.06%	Gross Margin	70.99%	52W Low	21.16%	ATR (14)	0.70
Dividend Ex-Date	Aug 16, 2024	Current Ratio	0.82	EPS Y/Y TTM	-71.48%	Oper. Margin	23.93%	RSI (14)	37.66	Volatility	1.45% 1.35%
Employees	70212	Debt/Eq	1.18	Sales Y/Y TTM	12.17%	Profit Margin	12.87%	Recom	2.30	Target Price	49.61
Option/Short	Yes / Yes	LT Debt/Eq	0.94	EPS Q/Q	-27.71%	Payout	47.48%	Rel Volume	1.39	Prev Close	41.62
Sales Surprise	5.82%	EPS Surprise	14.01%	Sales Q/Q	10.70%	Earnings	Jul 31 BMO	Avg Volume	3.59M	Price	40.80
SMA20	-5.71%	SMA50	-1.10%	SMA200	-0.40%	Trades		Volume	4,971,703	Change	-1.97%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral
Sep-08-22	Downgrade	Jefferies	Buy → Hold	$50.50 → $34
Aug-05-22	Resumed	Morgan Stanley	Equal-Weight
Jul-21-22	Resumed	Citigroup	Neutral
Feb-11-22	Downgrade	DZ Bank	Buy → Hold
Nov-05-21	Upgrade	Barclays	Underweight → Equal Weight
Jun-24-21	Upgrade	Deutsche Bank	Sell → Hold

Show Previous Ratings

Sep-19-24 08:00AM	Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024) (GlobeNewswire)
Sep-18-24 10:01AM	GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults (Benzinga)
07:00AM	GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX (Business Wire)
Sep-16-24 01:04PM	Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk (PR Newswire)
Sep-12-24 10:07AM	Gilead Stock Rises on Positive Study Results for Twice-Yearly HIV Drug (The Wall Street Journal)
05:38AM	Loading…
Sep-11-24 05:38AM	Buyout Firm GTCR Is in Advanced Talks to Acquire German Drugmaker Stada (Bloomberg)
Aug-30-24 11:31AM	Why Is Glaxo (GSK) Up 10.3% Since Last Earnings Report? (Zacks)
Aug-28-24 11:23AM	GSK plc (GSK): A Cheap Pharmaceutical Stock to Buy According to Short Sellers (Insider Monkey)
05:30AM	GSK shares rise on Delaware Supreme Court appeal in Zantac case (Investing.com)
Aug-23-24 05:32AM	Jim Cramer's Latest Lightning Round: Top 10 Stocks (Insider Monkey)
Aug-21-24 07:32AM	GSK's B7-H3-targeted ADC receives FDA breakthrough therapy status (Pharmaceutical Business Review)
Aug-17-24 03:58PM	Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now? (Insider Monkey)
Aug-10-24 12:57PM	GSK plc (GSK): Why Are Hedge Funds Bullish on This Undervalued UK Stock Now? (Insider Monkey)
Aug-06-24 04:05PM	Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12% (GlobeNewswire)
08:30AM	Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033 (GlobeNewswire)
04:32AM	Loading…
04:32AM	GSK announces victory in Zantac cancer claim lawsuit (Pharmaceutical Technology)
Aug-01-24 03:44PM	US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit (Business Wire)
02:31PM	Who's to blame as Moderna's stock falls amid slashed guidance? (Yahoo Finance)
Jul-31-24 11:51AM	Analyst Report: GSK plc (Morningstar Research)
11:27AM	British Pharma Giant GSK's Blockbuster Shingles And Respiratory Syncytial Virus Vaccine Q2 Sales Miss Expectations, Cuts Annual Vaccine Revenue Guidance (Benzinga)
08:42AM	GSK Becomes Latest Pharma Firm To Lift Outlook (Investopedia)
08:01AM	ViiV Healthcare announces positive data demonstrating 2-drug regimen DOVATO is as effective as 3-drug regimen BIKTARVY for maintenance therapy of HIV-1 (PR Newswire)
07:05AM	GSK (GSK) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:42AM	GSK Lifts Guidance After HIV, Cancer Treatments Boost Sales (The Wall Street Journal)
02:45AM	GSK Lifts Guidance After Higher Turnover Beats Market Views (The Wall Street Journal)
Jul-29-24 07:00AM	GSK and Flagship Pioneering partner to discover novel medicines and vaccines (PR Newswire)
Jul-24-24 10:01AM	GSK (GSK) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-22-24 06:24AM	3 Stocks Under $10 With the Potential for Massive Gains (InvestorPlace)
Jul-17-24 08:00AM	Is GSK a Top Value Stock Right Now? (Motley Fool)
06:30AM	3 Top Cancer Treatment Stocks to Buy Now (InvestorPlace)
09:40AM	Loading…
Jul-16-24 09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
Jul-12-24 06:15AM	The 3 Most Undervalued Pharma Stocks to Buy in July 2024 (InvestorPlace)
Jul-11-24 08:00AM	GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season (Business Wire)
07:00AM	3 Dirt-Cheap Drug Developers With Blockbuster Potential (InvestorPlace)
Jul-09-24 01:30PM	The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024 (InvestorPlace)
12:33PM	iTeos and GSK hit enrolment milestone with Phase III TIGIT lung cancer trial (Pharmaceutical Technology)
Jul-08-24 11:42PM	GSK plc (GSK): Is It the Best FTSE Dividend Stock to Buy According to Hedge Funds? (Insider Monkey)
01:30PM	Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows (Benzinga)
12:34PM	10 Best FTSE Dividend Stocks To Buy Now (Insider Monkey)
Jul-04-24 12:00PM	Upcoming Stock Spinoffs: Should You Pounce or Pass? (InvestorPlace)
10:01AM	3 Undervalued Biotech Gems With 200%+ Analyst Price Targets (InvestorPlace)
Jul-03-24 12:49PM	GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines (Investopedia)
11:49AM	CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts (InvestorPlace)
10:09AM	CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK (InvestorPlace)
08:19AM	Stocks to Watch Wednesday: Paramount, Tesla, Constellation Brands (The Wall Street Journal)
06:23AM	GSK to Buy CureVacs Covid-19, Flu Vaccine Rights for Up to $1.56 Billion (The Wall Street Journal)
05:21AM	3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024 (Motley Fool)
04:43AM	GSK pays CureVac $430M for mRNA vaccines against flu and COVID as partner lays off 30% (FierceBiotech.com)
02:40AM	GSK and CureVac to Restructure Collaboration into New Licensing Agreement (ACCESSWIRE)
Jul-01-24 10:24AM	Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons (Bloomberg)
Jun-27-24 10:05PM	20 Most Technologically Advanced Cities in the US (Insider Monkey)
03:28PM	American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond (PR Newswire)
03:13PM	GSK plc (GSK): Did This Healthcare Stock Show a Strong Performance in Q1? (Insider Monkey)
11:08AM	Analyst Report: GSK plc (Morningstar Research)
10:07AM	GSK stock falls as CDC shifts RSV vaccine recommendation (Yahoo Finance Video)
09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
08:40AM	GSK Shares Slump After CDC Narrows Age Recommendation for RSV Shots (The Wall Street Journal)
07:53AM	CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK (Benzinga)
03:16AM	Micron, Levi Strauss, Walgreens and International Paper fall premarket (Investing.com)
Jun-26-24 10:12PM	10 Best Healthcare Stocks to Buy Under $50 (Insider Monkey)
05:05PM	S&P 500 Gains and Losses Today: FedEx Stock Delivers Big Boost After Earnings Beat (Investopedia)
12:54PM	Why Is Moderna Stock Trading Lower On Wednesday? (Benzinga)
12:22PM	Moderna shares decline, RSV vaccine efficacy lags behind competitors (Investing.com)
Jun-24-24 01:02PM	Britain snubs GSK in favour of US pharma giant for RSV vaccine (The Telegraph)
Jun-20-24 10:00AM	Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth (GlobeNewswire)
Jun-16-24 08:00AM	The heartburn drug giving British pharma giant GSK a $3bn headache (The Telegraph)
08:00AM	The $3bn crisis casting a shadow over Dame Emma Walmsleys GSK (The Telegraph)
Jun-14-24 06:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
07:15AM	7 A-Rated Biotech Stocks Worth Betting on in June (InvestorPlace)
Jun-12-24 09:03AM	GSK signs AI pact with Ochre to pinpoint source of liver diseases (FierceBiotech.com)
Jun-11-24 09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
06:00AM	3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition (InvestorPlace)
05:05AM	GSK Says Individual Plaintiff in Latest Zantac Case Dropped Claim (The Wall Street Journal)
Jun-07-24 06:57PM	US FDA Approves Expanded Age Indication for GSKs AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk (Business Wire)
11:36AM	The City With the highest HIV/AIDS Rates in the US (Insider Monkey)
11:35AM	20 Cities With the Highest HIV/AIDS Rates in the US (Insider Monkey)
Jun-06-24 05:23PM	The 3 Most Undervalued Pharma Stocks to Buy in June 2024 (InvestorPlace)
09:03AM	GSK, after 11-month romance, buys oligonucleotide partner Elsie for up to $50M (FierceBiotech.com)
Jun-04-24 07:15AM	GSK shares fall 9% in wake of Zantac court ruling (Pharmaceutical Technology)
Jun-03-24 05:08PM	GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated Multiple Myeloma (Benzinga) -8.69%
03:44PM	GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know. (InvestorPlace)
01:42PM	Top Stock Movers Now: GameStop, Paramount Global, Waste Management, and More (Investopedia)
01:19PM	GSK Stock Slumps on Zantac Setback (The Wall Street Journal)
01:17PM	Oil price slumps by 4pc despite Opec cuts (The Telegraph)
12:18PM	Analyst Report: GSK plc (Morningstar Research)
11:53AM	Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move Forward (Benzinga)
11:46AM	GSK Stock Dives After Judge Allows Zantac Cancer Lawsuits To Go Forward (Investopedia)
11:30AM	Stocks to Watch Monday: GameStop, AMC, Paramount, Nvidia (The Wall Street Journal)
10:52AM	GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware (Bloomberg)
10:13AM	GSK stock sinks after court allows Zantac lawsuits to proceed (Yahoo Finance Video)
08:10AM	Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer (Business Wire)
07:05AM	GameStop rallies on Roaring Kitty position, chipmakers in focus: Yahoo Finance (Yahoo Finance Video)
Jun-02-24 10:56AM	Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma (Business Wire)
May-31-24 05:01PM	S&P 500 Gains and Losses Today: Caesars Entertainment Jumps on News of Icahn Stake (Investopedia) -8.69%
12:18PM	15 Most Profitable Biotechnology Companies in the World (Insider Monkey)
12:07PM	Moderna Looks for Boost From Newly Approved RSV Shot (The Wall Street Journal)
11:31AM	Glaxo (GSK) Up 1.6% Since Last Earnings Report: Can It Continue? (Zacks)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
May-24-24 03:45PM	Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit (Benzinga)
08:04AM	23andMe Holding Co. (NASDAQ:ME) Q4 2024 Earnings Call Transcript (Insider Monkey)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Dec 07 '23	Buy	5.00	3,300,000	16,500,000	13,983,761	Jan 30 04:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK

GSK Plc ADR

Upgrade your FINVIZ experience